|

CXR Biosciences is committed to accelerating drug development, reducing late stage product attrition, and accurately determining the safety characteristics of chemicals....
 

CXR Biosciences: your partner in preclinical problem solving

At CXR, we use our extensive industry experience and understanding of biological mechanisms to deliver tailored preclinical services:

  • Investigative and Mechanistic Toxicology: By understanding the pathways that define the sensitivity of cells to chemicals, we evaluate the actual hazard to man, and rescue chemicals and drugs that may otherwise be abandoned.
  • Exploratory & Discovery Toxicology: In order to improve productivity, CXR can help you shift the identification of potential toxic hazard and risk from the development stage to the research stage of R&D.
  • Novel Technologies: Commercialising innovative preclinical tools which allow improved safety and DMPK prediction in man.

                   

 


               




  Manuscripts describing novel CYP2C9 and MRP2 humanized ..
Taconic and CXR Biosciences Ltd are pleased to announce the publication of two manuscripts describing novel mouse lines humanized for the important dr... »
  CXR Biosciences® announces the opening of its first USA..
In response to the growing North American demand for its investigative toxicology and DMPK services, CXR Biosciences® is pleased to announce the openi... »
  Drug-drug interaction study using triple humanized mous..
CXR Biosciences Ltd and Taconic are pleased to announce the publication of a collaborative study with the Japanese Pharmaceutical company Kyowa Hakko ... »
 

© Copyright CXR Biosciences Scotland 2007 | James Lindsay Place, Dundee Technopole, Dundee, Scotland DD1 5JJ Tel +44 1382 432163
Web Design, Development and hosting by MTC Media